In vivo measurement of tumor estradiol and Vascular Endothelial Growth Factor in breast cancer patients
Open Access
- 18 March 2008
- journal article
- Published by Springer Nature in BMC Cancer
- Vol. 8 (1) , 73
- https://doi.org/10.1186/1471-2407-8-73
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Estradiol increases VEGF in human breast studied by whole-tissue cultureCell and tissue research, 2006
- Positive Correlation between Estradiol and Vascular Endothelial Growth Factor but not Fibroblast Growth Factor-2 in Normal Human Breast Tissue In vivoClinical Cancer Research, 2005
- Tamoxifen inhibits secretion of vascular endothelial growth factor in breast cancer in vivo.2003
- Estradiol increases extracellular levels of vascular endothelial growth factor in vivo in murine mammary cancerInternational Journal of Cancer, 2003
- Correlation of Vascular Endothelial Growth Factor Content With Recurrences, Survival, and First Relapse Site in Primary Node-Positive Breast Carcinoma After Adjuvant TreatmentJournal of Clinical Oncology, 2000
- Vascular endothelial growth factor is of high prognostic value in node-negative breast carcinoma.Journal of Clinical Oncology, 1998
- Progestin regulation of vascular endothelial growth factor in human breast cancer cells.1998
- The Biology of Vascular Endothelial Growth FactorEndocrine Reviews, 1997
- Tumor angiogenesis in breast cancer: Its importance as a prognostic indicator and the association with vascular endothelial growth factor expressionBreast Cancer Research and Treatment, 1995
- Angiogenesis in cancer, vascular, rheumatoid and other diseaseNature Medicine, 1995